Abstract | UNLABELLED: OBJECTIVE: METHODS: Hundred and fifty-one patients over 18 years of age were included in this study. Patients were randomized and divided into five groups. They received clarithromycin, erythromycin, fusidic acid cream, placebo cream or placebo tablets. Patients were evaluated by Wood's light reflection scores and the initial score values and the values on the days of 2, 7 and 14 were compared statistically. RESULTS: CONCLUSION: Topical fusidic acid proved to be the most effective treatment; however, clarithromycin therapy may be an alternative regimen in the treatment of erythrasma because of its efficiency and better patient's compliance.
|
Authors | Oktay Avci, Taner Tanyildizi, Ergun Kusku |
Journal | The Journal of dermatological treatment
(J Dermatolog Treat)
Vol. 24
Issue 1
Pg. 70-4
(Feb 2013)
ISSN: 1471-1753 [Electronic] England |
PMID | 21923567
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Anti-Bacterial Agents
- Fusidic Acid
- Erythromycin
- Clarithromycin
|
Topics |
- Adolescent
- Adult
- Aged
- Anti-Bacterial Agents
(therapeutic use)
- Clarithromycin
(therapeutic use)
- Double-Blind Method
- Erythrasma
(drug therapy)
- Erythromycin
(therapeutic use)
- Female
- Fusidic Acid
(therapeutic use)
- Humans
- Male
- Middle Aged
- Skin Cream
- Skin Diseases, Bacterial
(drug therapy)
- Treatment Outcome
- Young Adult
|